Prime Therapeutics to present latest industry-leading research at AMCP 2026
Three studies to be recognized with awards
Prime Therapeutics (Prime) will present industry-leading insights on a range of healthcare topics and trends at the Academy of Managed Care Pharmacy (AMCP)annual meeting from April 13–16 in Nashville, Tennessee.
Prime researchers will present 10 research posters and lead additional education sessions as part of its presence this year. Among the research studies to be presented at AMCP 2026:
Real-World Treatment-Adherent 3-Year Cost Impact Assessment of Glucagon-Like Peptide-1 Agonists to Treat Obesity Among Commercially Insured Members Without Diabetes — This study earned a gold award from AMCP.
Real-World 3-Year Cost Impact Assessment of Glucagon-Like Peptide-1 Agonists to Treat Obesity Among Commercially Insured Members without Diabetes — This study earned a silver award from AMCP.
The Value of Pharmacy Benefit Integration: A Retrospective Comparison of Health Care Costs and Utilization, 2022-2023 — This study earned a silver award from AMCP.
As part of its program to support the next generation of researchers, Prime residents will present two additional studies at AMCP 2026:
Prime researchers and subject matter experts will participate in several education sessions during the event. Visit the AMCP 2026 agenda for more information, and for more on these latest studies, and further insights from the event, visit the Prime newsroom.
Contact
Alex Cook
Senior Public Relations Manager
612.777.4217
Alex.Cook2@PrimeTherapeutics.com
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.